Back to search

United States· US:84753-040_4dade579-ce78-eea5-e063-6394a90ad46a

HALORINNA SUN-SCREEN TRAVEL SPF50

A medicinal product containing phenylbenzimidazole sulfonic acid; ethylhexyl methoxycinnamate; butyl methoxydibenzoylmethane; octocrylene; ci 77891, registered in United States by Guangdong Bisutang Biotechnology Co., LTD.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedHALORINNA SUN-SCREEN TRAVEL SPF50ATC—REGISTER NO.US:84753-040_4dade579…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
PHENYLBENZIMIDAZOLE SULFONIC ACID; ETHYLHEXYL METHOXYCINNAMATE; BUTYL METHOXYDIBENZOYLMETHANE; OCTOCRYLENE; CI 77891
Manufacturer
Guangdong Bisutang Biotechnology Co., LTD
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    8475304001
    50 mL in 1 BOTTLE (84753-040-01)
  • ndc11
    84753-040-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/17869d27-a09d-4fb5-ac2b-29f8b088d725
GET /v1/drugs/17869d27-a09d-4fb5-ac2b-29f8b088d725?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": "2; 7.5; 2; 3.4937; 1.8",
  "substance": "PHENYLBENZIMIDAZOLE SULFONIC ACID; ETHYLHEXYL METHOXYCINNAMATE; BUTYL METHOXYDIBENZOYLMETHANE; OCTOCRYLENE; CI 77891",
  "productndc": "84753-040",
  "dosage_form": "LOTION",
  "dea_schedule": null,
  "strength_unit": "g/100mL; g/100mL; g/100mL; g/100mL; g/100mL",
  "application_number": "M020",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about phenylbenzimidazole sulfonic acid; ethylhexyl methoxycinnamate; butyl methoxydibenzoylmethane; octocrylene; ci 77891.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.